BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ulkoski D, Bak A, Wilson JT, Krishnamurthy VR. Recent advances in polymeric materials for the delivery of RNA therapeutics. Expert Opin Drug Deliv 2019;16:1149-67. [PMID: 31498013 DOI: 10.1080/17425247.2019.1663822] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Gote V, Bolla PK, Kommineni N, Butreddy A, Nukala PK, Palakurthi SS, Khan W. A Comprehensive Review of mRNA Vaccines. IJMS 2023;24:2700. [DOI: 10.3390/ijms24032700] [Reference Citation Analysis]
2 Winkeljann B, Keul DC, Merkel OM. Engineering poly- and micelleplexes for nucleic acid delivery - A reflection on their endosomal escape. J Control Release 2023;353:518-34. [PMID: 36496051 DOI: 10.1016/j.jconrel.2022.12.008] [Reference Citation Analysis]
3 Wang X, Zhang Z, Hadjichristidis N. Poly(amino ester)s as an emerging synthetic biodegradable polymer platform: Recent developments and future trends. Progress in Polymer Science 2022. [DOI: 10.1016/j.progpolymsci.2022.101634] [Reference Citation Analysis]
4 Viegas JSR, Bentley MVLB, Vicentini FTMDC. Challenges to perform an efficiently gene therapy adopting non-viral vectors: Melanoma landscape. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103964] [Reference Citation Analysis]
5 Toudeshkchouei MG, Tavakoli A, Mohammadghasemi H, Karimi A, Ai J, Rabiee M, Rabiee N. Recent approaches to mRNA vaccine delivery by lipid-based vectors prepared by continuous-flow microfluidic devices. Future Medicinal Chemistry 2022. [DOI: 10.4155/fmc-2022-0027] [Reference Citation Analysis]
6 Yadav K, Singh D, Singh MR, Minz S, Sahu KK, Kaurav M, Pradhan M. Dermal nanomedicine: Uncovering the ability of nucleic acid to alleviate autoimmune and other related skin disorders. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103437] [Reference Citation Analysis]
7 Karmacharya P, Patil BR, Kim JO. Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy. J Pharm Investig . [DOI: 10.1007/s40005-022-00569-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Taina-González L, de la Fuente M. The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA. Pharmaceutics 2022;14:460. [PMID: 35214191 DOI: 10.3390/pharmaceutics14020460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ljubimov VA, Ramesh A, Davani S, Danielpour M, Breunig JJ, Black KL. Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic. Adv Drug Deliv Rev 2022;181:114033. [PMID: 34808227 DOI: 10.1016/j.addr.2021.114033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tsou H, Chang C, Maeda T, Lin C. Preparation of Messenger RNA-Loaded Nanomedicine Applied on Tissue Engineering and Regenerative Medicine. RNA Technologies 2022. [DOI: 10.1007/978-3-031-08415-7_18] [Reference Citation Analysis]
11 Gómez-aguado I, Rodríguez-castejón J, Beraza-millor M, Rodríguez-gascón A, del Pozo-rodríguez A, Solinís MÁ. mRNA delivery technologies: Toward clinical translation. mRNA-Based Therapeutics 2022. [DOI: 10.1016/bs.ircmb.2022.04.010] [Reference Citation Analysis]
12 Ouranidis A, Vavilis T, Mandala E, Davidopoulou C, Stamoula E, Markopoulou CK, Karagianni A, Kachrimanis K. mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines 2022;10:50. [DOI: 10.3390/biomedicines10010050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Ding G, Ma X, Meng X, Yang P, Stauber RH, Li Z. pH low insertion peptide (pHLIP)-decorated polymeric nanovehicle for efficient and pH-responsive siRNA translocation. Materials & Design 2021;212:110197. [DOI: 10.1016/j.matdes.2021.110197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Żak MM, Zangi L. Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery. Pharmaceutics 2021;13:1675. [PMID: 34683969 DOI: 10.3390/pharmaceutics13101675] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Choi M, Thuy LT, Lee Y, Piao C, Choi JS, Lee M. Dual-Functional Dendrimer Micelles with Glycyrrhizic Acid for Anti-Inflammatory Therapy of Acute Lung Injury. ACS Appl Mater Interfaces 2021;13:47313-26. [PMID: 34581558 DOI: 10.1021/acsami.1c08107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
16 Uddin MN, Roni MA. Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines. Vaccines (Basel) 2021;9:1033. [PMID: 34579270 DOI: 10.3390/vaccines9091033] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 21.0] [Reference Citation Analysis]
17 Ho W, Gao M, Li F, Li Z, Zhang XQ, Xu X. Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery. Adv Healthc Mater 2021;10:e2001812. [PMID: 33458958 DOI: 10.1002/adhm.202001812] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 37.0] [Reference Citation Analysis]
18 Patel P, Ibrahim NM, Cheng K. The Importance of Apparent pKa in the Development of Nanoparticles Encapsulating siRNA and mRNA. Trends Pharmacol Sci 2021;42:448-60. [PMID: 33875229 DOI: 10.1016/j.tips.2021.03.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
19 Mani H, Chen YC, Chen YK, Liu WL, Lo SY, Lin SH, Liou JW. Nanosized Particles Assembled by a Recombinant Virus Protein Are Able to Encapsulate Negatively Charged Molecules and Structured RNA. Polymers (Basel) 2021;13:858. [PMID: 33799623 DOI: 10.3390/polym13060858] [Reference Citation Analysis]
20 Ashford MB, England RM, Akhtar N. Highway to Success—Developing Advanced Polymer Therapeutics. Adv Therap 2021;4:2000285. [DOI: 10.1002/adtp.202000285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ulkoski D, Munson MJ, Jacobson ME, Palmer CR, Carson CS, Sabirsh A, Wilson JT, Krishnamurthy VR. High-Throughput Automation of Endosomolytic Polymers for mRNA Delivery. ACS Appl Bio Mater 2021;4:1640-54. [DOI: 10.1021/acsabm.0c01463] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
22 Song H, Hart SL, Du Z. Assembly strategy of liposome and polymer systems for siRNA delivery. International Journal of Pharmaceutics 2021;592:120033. [DOI: 10.1016/j.ijpharm.2020.120033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
23 Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov 2021;20:817-38. [PMID: 34433919 DOI: 10.1038/s41573-021-00283-5] [Cited by in Crossref: 254] [Cited by in F6Publishing: 244] [Article Influence: 127.0] [Reference Citation Analysis]
24 Jiang X, Abedi K, Shi J. Polymeric nanoparticles for RNA delivery. Reference Module in Materials Science and Materials Engineering 2021. [DOI: 10.1016/b978-0-12-822425-0.00017-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Iqbal S, Qu Y, Dong Z, Zhao J, Rauf Khan A, Rehman S, Zhao Z. Poly (β‐amino esters) based potential drug delivery and targeting polymer; an overview and perspectives (review). European Polymer Journal 2020;141:110097. [DOI: 10.1016/j.eurpolymj.2020.110097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
26 Moradian H, Lendlein A, Gossen M. Strategies for simultaneous and successive delivery of RNA. J Mol Med (Berl) 2020;98:1767-79. [PMID: 33146744 DOI: 10.1007/s00109-020-01956-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
27 Noske S, Karimov M, Aigner A, Ewe A. Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Knockdown. Nanomaterials (Basel) 2020;10:E1809. [PMID: 32927826 DOI: 10.3390/nano10091809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Uchida S, Perche F, Pichon C, Cabral H. Nanomedicine-Based Approaches for mRNA Delivery. Mol Pharm 2020;17:3654-84. [PMID: 32845639 DOI: 10.1021/acs.molpharmaceut.0c00618] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 12.7] [Reference Citation Analysis]
29 Wen Y, Bai H, Zhu J, Song X, Tang G, Li J. A supramolecular platform for controlling and optimizing molecular architectures of siRNA targeted delivery vehicles. Sci Adv 2020;6:eabc2148. [PMID: 32832695 DOI: 10.1126/sciadv.abc2148] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
30 Rosenblum D, Gutkin A, Dammes N, Peer D. Progress and challenges towards CRISPR/Cas clinical translation. Adv Drug Deliv Rev 2020;154-155:176-86. [PMID: 32659256 DOI: 10.1016/j.addr.2020.07.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
31 Piotrowski-Daspit AS, Kauffman AC, Bracaglia LG, Saltzman WM. Polymeric vehicles for nucleic acid delivery. Adv Drug Deliv Rev 2020;156:119-32. [PMID: 32585159 DOI: 10.1016/j.addr.2020.06.014] [Cited by in Crossref: 43] [Cited by in F6Publishing: 52] [Article Influence: 14.3] [Reference Citation Analysis]
32 Gómez-Aguado I, Rodríguez-Castejón J, Vicente-Pascual M, Rodríguez-Gascón A, Solinís MÁ, Del Pozo-Rodríguez A. Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives. Nanomaterials (Basel) 2020;10:E364. [PMID: 32093140 DOI: 10.3390/nano10020364] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 26.3] [Reference Citation Analysis]
33 Wadhwa A, Aljabbari A, Lokras A, Foged C, Thakur A. Opportunities and Challenges in the Delivery of mRNA-based Vaccines. Pharmaceutics 2020;12:E102. [PMID: 32013049 DOI: 10.3390/pharmaceutics12020102] [Cited by in Crossref: 174] [Cited by in F6Publishing: 181] [Article Influence: 58.0] [Reference Citation Analysis]
34 Okay S, Özge Özcan Ö, Karahan M; 1 Department of Vaccine Technology, Vaccine Institute, Hacettepe University, Ankara, Turkey, 2 Department of Molecular Neuroscience, Institute of Health Sciences, Üsküdar University, Istanbul, Turkey, 3 Department of Nutrition and Dietetics, Faculty of Health Sciences, Üsküdar University, Istanbul, Turkey. . AIMS Biophysics 2020;7:323-38. [DOI: 10.3934/biophy.2020023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ewe A, Noske S, Karimov M, Aigner A. Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA Delivery. Pharmaceutics 2019;11:E600. [PMID: 31726756 DOI: 10.3390/pharmaceutics11110600] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]